{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://www.yso.fi/onto/yso/p20931",
      "name": "non-Hodgkin-lymfoomat"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00576213600",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Prognostic molecular factors and algorithms in diffuse large B-cell lymphoma"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00526538800",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Kolhittu"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00301078400",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma : progenitor cell mobilisation, toxicity of high-dose therapy, and progressive disease after transplantation"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W01261954700",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Graft and outcome in autologous stem cell transplantation"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00656928600",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Lasten imukudoskasvaimet eli lymfoomat"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00054398900",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": "Circadian rhythm disruptions and health"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00245183700",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p20931"
      },
      "name": [
        "Resistance mechanisms of non-Hodgkin lymphomas against Rituximab treatment",
        "Resistance mechanisms of non-Hodgkin lymphomas against rituximab treatment"
      ]
    }
  ]
}